Ginsenoside Rb1 ameliorates hippocampal neuroinflammation in rats after intracerebral hemorrhage by inactivating the TLR4/NF-kB pathway
Journal of Pharmacy and Pharmacology · 04.03.2025 · 77 (3) · 386-395
DOI: 10.1093/jpp/rgae145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 26.11.2024. Verfasst von Xi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Changsha Hospital of Traditional Chinese Medicine, Changsha City, Hunan Province, China. Hauptthemen laut MEDLINE: Ginsenosides, Toll-Like Receptor 4, Hippocampus, Cerebral Hemorrhage. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Natural Science Foundation of Changsha City, Scientific research projects of Chinese medicine in Hunan Province, Scientific Research Topics of Changsha Municipal Health and Wellness Committee.
Abstract (Originalsprache)
Purpose
This work elucidated the therapeutic effect and mechanism of ginsenoside Rb1 on intracerebral hemorrhage (ICH).
Methods
ICH rat models were treated by ginsenoside Rb1. Modified neurological deficit score, and Y-maze and Morris water-maze tests were performed on rats. Hippocampal neuronal damage was observed by Nissl staining. Rat primary astrocytes were exposed to ginsenoside Rb1, Hemin, and lipopolysaccharide (LPS). TNF-α, IL-1β, and IL-6 levels were assessed via enzyme-linked immunosorbent assay. TLR4/NF-kB pathway activity was appraised by Western blot. Immunofluorescence staining was for hippocampal glial fibrillary acidic protein (GFAP) expression and P65 protein location in hippocampus and astrocytes.
Results
In rats after ICH, ginsenoside Rb1 ameliorated neurological impairment and hippocampal neuronal damage; improved learning and memory ability; reduced brain water content; decreasedhippocampal TNF-α, IL-1β, and IL-6; inactivated TLR4/NF-kB pathway; and declined hippocampal GFAP expression. In rat primary astrocytes exposed to Hemin, ginsenoside Rb1 declined TNF-α, IL-1β, and IL-6; inactivated TLR4/NF-kB pathway; and hindered P65 protein entry into nucleus. However, these functions of ginsenoside Rb1 on the Hemin-induced astrocytes were abolished by LPS.
Conclusion
Ginsenoside Rb1 has promising future for clinical ICH treatment, which exerts therapeutic effect on ICH by ameliorating hippocampal neuroinflammation via inactivating the TLR4/NF-kB pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Changsha Hospital of Traditional Chinese Medicine, Changsha City, Hunan Province, China.
- School of Stomatology, Hunan University of Chinese Medicine, Changsha City, Hunan Province, China.
- Department of Neurosurgery, Hunan Aerospace Hospital, Changsha City, Hunan Province, China.
ORCID-Profile: Zhijun Zhong
Förderung
- Natural Science Foundation of Changsha City
- Scientific research projects of Chinese medicine in Hunan Province
- Scientific Research Topics of Changsha Municipal Health and Wellness Committee
Zitieren
APA
Liu, X., Wang, Y., Han, L., Li, X., Zhong, Y., Zhou, J., Fei, X., Peng, M., Duan, J., & Zhong, Z. (2025). Ginsenoside Rb1 ameliorates hippocampal neuroinflammation in rats after intracerebral hemorrhage by inactivating the TLR4/NF-kB pathway. Journal of Pharmacy and Pharmacology, 77(3), 386-395. https://doi.org/10.1093/jpp/rgae145
Vancouver
Liu X, Wang Y, Han L, Li X, Zhong Y, Zhou J, et al. Ginsenoside Rb1 ameliorates hippocampal neuroinflammation in rats after intracerebral hemorrhage by inactivating the TLR4/NF-kB pathway. Journal of Pharmacy and Pharmacology. 2025;77(3):386-395. doi:10.1093/jpp/rgae145
BibTeX
@article{Liu2025,
author = {Liu, Xi and Wang, Yuying and Han, Ling and Li, Xing and Zhong, Yan and Zhou, Jilin and Fei, Xiyun and Peng, Min and Duan, Jixin and Zhong, Zhijun},
title = {Ginsenoside Rb1 ameliorates hippocampal neuroinflammation in rats after intracerebral hemorrhage by inactivating the TLR4/NF-kB pathway},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
volume = {77},
number = {3},
pages = {386--395},
doi = {10.1093/jpp/rgae145}
}
EUVIMED